Home » Healthcare » Canada Single-Use Bio-Processing Systems Market

Canada Single-Use Bio-Processing Systems Market

Canada Single-Use Bio-Processing Systems Market By Type (Single-Use Bioreactors, Single-Use Mixers, Single-Use Bags, Single-Use Connectors, Others); By Application (Research & Development, Manufacturing, Process Development, Commercial Production, Others); By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations [CROs], Academic & Research Institutes, Contract Manufacturing Organizations [CMOs], Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2020-2023
Base Year	2024
Forecast Period	2025-2032
Canada Single-Use Bio-Processing Systems Market Size 2024	USD 583.42 million
Canada Single-Use Bio-Processing Systems Market, CAGR	15.48%
Canada Single-Use Bio-Processing Systems Market Size 2032	USD 1,845.36 million

Market Overview

Canada Single-Use Bio-Processing Systems market size was valued at USD 583.42 million in 2024 and is anticipated to reach USD 1,845.36 million by 2032, at a CAGR of 15.48% during the forecast period (2024-2032).

The Canada Single-Use Bio-Processing Systems market is driven by the growing demand for cost-effective, flexible, and scalable biomanufacturing solutions. Single-use technologies offer significant advantages, such as reduced contamination risk, shorter production timelines, and lower capital investment compared to traditional stainless-steel systems. The increasing prevalence of biologics and biosimilars, along with the rising demand for personalized medicines, further accelerates market growth. Additionally, the shift towards more sustainable and efficient manufacturing processes in the biopharmaceutical industry fuels adoption. Technological advancements in single-use systems, including improved materials and enhanced system integration, also contribute to market expansion. These factors, combined with the growing emphasis on minimizing production costs and optimizing throughput, position Canada’s single-use bio-processing systems market for continued growth through the forecast period.

The geographical landscape of the Canada Single-Use Bio-Processing Systems market is marked by significant regional activity, with Ontario, Quebec, and Western Canada leading the adoption of single-use technologies due to their strong biotechnology sectors and growing pharmaceutical industries. Ontario, with its biotech hubs like Toronto, is a major player in the market, driven by substantial investments in life sciences and biomanufacturing. Quebec follows closely, bolstered by its thriving biotech ecosystem in Montreal. Western Canada, particularly Alberta, is also seeing growth, supported by government initiatives and biotech firms looking to enhance production flexibility. Key players driving innovation and market growth in Canada include Thermo Fisher Scientific Inc., Danaher Corporation, Corning Incorporated, and Pall Corporation. These companies, along with others like Avantor and Meissner Filtration Products, offer a range of solutions, including bioreactors, mixers, and filtration systems, which are essential for scalable, efficient biomanufacturing in the region.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

Market Insights

The Canada Single-Use Bio-Processing Systems market was valued at USD 583.42 million in 2024 and is expected to reach USD 1,845.36 million by 2032, growing at a CAGR of 15.48% during the forecast period (2024-2032).

The global single-use bio-processing systems market was valued at USD 17,326.05 million in 2024 and is projected to reach USD 57,663.39 million by 2032, growing at a CAGR of 16.22% from 2024 to 2032.

Market growth is driven by the increasing demand for cost-effective, flexible biomanufacturing solutions, particularly in biologics and biosimilars production.
Technological advancements, such as automation and real-time data integration, are enhancing the efficiency and scalability of single-use systems.
The adoption of hybrid biomanufacturing models combining single-use and traditional systems is on the rise.
Key players in the market include Thermo Fisher Scientific, Danaher Corporation, Corning, and Pall Corporation, which dominate with advanced solutions.
Market restraints include scalability challenges for large-scale production and concerns about the environmental impact of single-use plastics.
Regional growth is strongest in Ontario, Quebec, and Western Canada, driven by biotechnology hubs and growing biomanufacturing infrastructure.

Report Scope

This report segments the Canada Single-Use Bio-Processing Systems Market as follows:

Market Drivers

Advancements in Biomanufacturing Technology

One of the primary drivers of the Canada Single-Use Bio-Processing Systems market is the continuous advancement in biomanufacturing technologies. Traditional stainless-steel systems have long been the standard, but they are now being overshadowed by single-use systems due to their cost-effectiveness and scalability. Single-use technologies have demonstrated significant benefits, including reduced risk of contamination, faster production cycles, and lower capital expenditures. For instance, the adoption of single-use bioprocessing technology has been driven by the growing demand for biopharmaceuticals and increased investments in biologics development. The ability to quickly scale up or down without major infrastructure changes has made single-use systems particularly attractive for biopharmaceutical companies. This shift in manufacturing processes allows companies to remain agile in an increasingly competitive market, enhancing the overall appeal of single-use systems.

Growing Demand for Biologics and Biosimilars

The increasing demand for biologics and biosimilars is another key driver in the growth of the single-use bio-processing systems market in Canada. Biologics, including monoclonal antibodies, vaccines, and gene therapies, are becoming more prevalent in the global healthcare landscape due to their effectiveness in treating a variety of diseases, particularly cancer, autoimmune disorders, and chronic conditions. Biosimilars, the cost-effective alternatives to biologics, are also gaining traction. The production of these biologics and biosimilars requires flexible, efficient, and scalable manufacturing solutions, which is where single-use bio-processing systems excel. For instance, the commercial success of biopharmaceuticals has led single-use manufacturers to expand their production facilities globally. Their ability to meet the stringent requirements of biologics production, while minimizing contamination and reducing operational costs, makes them an ideal choice for manufacturers.

Cost Reduction and Efficiency Gains

Single-use bio-processing systems offer significant cost reduction advantages over traditional manufacturing methods, making them particularly attractive to the Canadian biopharmaceutical industry. The initial capital investment required for single-use systems is significantly lower compared to the large, complex infrastructure needed for stainless-steel systems. Additionally, single-use systems minimize the need for cleaning and sterilization, which not only reduces operational downtime but also lowers overall maintenance costs. As a result, companies can achieve faster product turnaround times, higher throughput, and reduced overall production expenses. These factors contribute to the growing adoption of single-use systems by manufacturers aiming to improve operational efficiency and increase profitability.

Increasing Focus on Sustainability and Regulatory Support

Sustainability and environmental concerns are becoming increasingly important in the biopharmaceutical industry. Single-use bio-processing systems contribute to sustainability by reducing water usage, energy consumption, and the generation of chemical waste associated with traditional biomanufacturing processes. Additionally, the growing emphasis on reducing the environmental impact of production processes aligns with the shift toward single-use technologies. Regulatory agencies in Canada and globally are also providing favorable conditions for the adoption of single-use systems, recognizing their benefits in terms of operational efficiency and product safety. With the Canadian government and international regulatory bodies offering support and establishing standards for single-use technologies, the market is poised for further growth. The combination of environmental benefits and regulatory backing strengthens the case for increased adoption of single-use bio-processing systems, further driving their market expansion.

Market Trends

Integration of Automation and Data Analytics

The integration of automation and data analytics is a prominent trend shaping the Canadian single-use bioprocessing market. Automated systems and real-time data solutions enhance process performance and data reliability. Automation improves product quality by enabling precise control over bioprocessing parameters, reducing variability, and minimizing human error. This trend is particularly significant in the production of biologics and biosimilars, where consistency and efficiency are paramount. The adoption of automated single-use systems allows manufacturers to streamline operations, reduce costs, and accelerate time-to-market for new therapies.

Expansion of Single-Use Applications Beyond Upstream Processing

While single-use technologies have traditionally been utilized in upstream processing, their application is expanding across the entire biomanufacturing workflow. In Canada, there is a growing adoption of single-use systems in downstream processes such as filtration, mixing, and storage. This expansion is driven by the need for efficient, scalable, and cost-effective solutions throughout the biomanufacturing process. For instance, advancements in single-use technologies, such as the development of high-quality plastic materials and improved process control, have enhanced the performance and reliability of these systems. The versatility of single-use systems allows for seamless integration into various stages of production, enhancing overall operational efficiency and reducing the risk of cross-contamination.

Increasing Regulatory Support and Standardization Efforts

Regulatory support and standardization efforts are evolving to accommodate the growing use of single-use technologies in Canada. Organizations such as the Bioprocess Systems Alliance (BPSA) are working to advance single-use technology and establish industry standards. These efforts aim to address challenges related to compatibility and interoperability among different single-use systems. For instance, regulatory agencies are increasingly supporting single-use technologies due to their ability to meet stringent safety and quality standards. As regulatory frameworks adapt to the widespread adoption of single-use technologies, manufacturers can expect clearer guidelines and increased confidence in the safety and efficacy of these systems. This trend is expected to further accelerate the adoption of single-use bioprocessing solutions across the Canadian biopharmaceutical industry.

Emergence of Hybrid Biomanufacturing Models

Hybrid biomanufacturing models, which combine single-use and traditional stainless-steel technologies, are gaining traction in Canada. These models offer flexibility to scale production up or down based on demand, optimizing resource utilization and cost efficiency. For instance, the integration of single-use systems in large-scale facilities enables rapid response to market needs without significant capital investment. This trend is particularly beneficial for contract manufacturing organizations (CMOs) and in-house manufacturers seeking to balance flexibility with cost control.

Market Challenges Analysis

Limited Scalability for Large-Scale Production

One of the key challenges facing the adoption of single-use bio-processing systems in Canada is their limited scalability for large-scale production. While single-use systems offer flexibility and cost savings at smaller or pilot scale, scaling these systems for large biomanufacturing operations can be complex. For instance, ensuring consistency across multiple single-use units in large volumes and maintaining high product quality standards can be difficult. The need for efficient transfer of knowledge from small-scale to large-scale production often presents challenges related to reproducibility, particularly in the context of biologics production. For instance, the Canadian biopharmaceutical sector has been investing in advanced manufacturing technologies to address scalability concerns and improve production efficiency. As manufacturers seek to expand their capacity, these scaling challenges can hinder the widespread adoption of single-use systems for large-scale commercial manufacturing, potentially limiting the growth of the market.

Concerns Over Waste Management and Sustainability

Although single-use bio-processing systems are often promoted as more environmentally sustainable due to reduced water and energy usage, concerns about waste management persist. The disposable nature of these systems results in significant plastic waste, which poses environmental challenges. In Canada, where sustainability is a growing concern, the accumulation of single-use plastics from biomanufacturing processes can contribute to increasing waste disposal costs and environmental impacts. While manufacturers are exploring ways to improve the recyclability of single-use components, there is still a lack of comprehensive solutions to address waste management effectively. Until significant advancements are made in recycling technologies and waste reduction practices, this challenge may limit the full-scale adoption of single-use bio-processing systems in the long term.

Market Opportunities

The Canadian market for single-use bio-processing systems presents significant opportunities driven by the increasing demand for biologics, biosimilars, and personalized medicines. As the biopharmaceutical industry shifts towards more flexible and cost-effective manufacturing solutions, single-use systems offer a clear advantage by reducing capital expenditures, operational complexity, and contamination risks. This flexibility is especially crucial in the production of biologics and biosimilars, where fast-tracking production while maintaining high-quality standards is essential. With the rising prevalence of chronic diseases, cancer, and autoimmune disorders, the demand for biologics is expected to grow, creating an expanded market for single-use systems to meet production needs efficiently. Additionally, the Canadian government’s support for the biotechnology sector, along with favorable regulatory frameworks, further enhances the growth potential for single-use bio-processing systems in the country.

Another key opportunity lies in the growing trend of hybrid biomanufacturing models, which combine single-use and traditional stainless-steel technologies. This allows manufacturers to balance flexibility and cost control while expanding capacity. Moreover, as the technology continues to evolve, the range of applications for single-use systems is broadening beyond upstream processes to include downstream applications such as filtration, mixing, and storage. This presents new growth avenues for single-use system suppliers to tap into, further diversifying their product offerings. Additionally, advancements in automation, real-time data analytics, and improved material science are paving the way for more efficient and sustainable bio-manufacturing solutions. By capitalizing on these trends and innovations, manufacturers and suppliers in the Canadian market can unlock significant opportunities for growth and position themselves at the forefront of the rapidly evolving biopharmaceutical industry.

Market Segmentation Analysis:

By Type:

The single-use bio-processing systems market in Canada is segmented by type, with key components including single-use bioreactors, mixers, bags, connectors, and others. Single-use bioreactors are the largest segment, driven by their critical role in the upstream biomanufacturing process. These bioreactors allow for scalable production without the need for cleaning and sterilization, making them ideal for the manufacture of biologics and biosimilars. Single-use mixers are also in high demand due to their ability to ensure proper homogenization and reduce the risk of contamination in liquid-based processes. Single-use bags are widely used for the storage and transportation of bioprocessing materials, providing an easy, cost-effective solution for fluid handling. Similarly, single-use connectors facilitate seamless fluid transfer between systems, minimizing the risk of contamination and reducing setup time. The “Others” segment includes various components such as filtration systems and storage tanks, which continue to gain adoption as the market expands to include more diverse applications.

By Application:

The market for single-use bio-processing systems in Canada is also segmented by application, including research and development (R&D), manufacturing, process development, commercial production, and others. Research and development hold a significant share due to the growing number of biotech startups and academic institutions that require flexible, scalable systems to conduct experiments and develop new therapeutics. Single-use systems provide a cost-effective solution for these R&D activities by reducing the need for expensive infrastructure. The manufacturing segment, driven by the need for large-scale biologics production, is a key area of focus, particularly as demand for biologics continues to rise. Process development is another important application, as biopharmaceutical companies increasingly adopt single-use systems to optimize their production processes. In commercial production, single-use bio-processing systems are integral to meeting the high demand for biologics and vaccines. The “Others” segment covers applications in specialized fields like gene therapy and vaccine production, which are increasingly incorporating single-use technologies due to their efficiency and scalability.

Segments:

Based on Type:

Single-Use Bioreactors
Single-Use Mixers
Single-Use Bags
Single-Use Connectors
Others

Based on Application:

Research & Development
Manufacturing
Process Development
Commercial Production
Others

Based on End- User:

Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Academic & Research Institutes
Contract Manufacturing Organizations (CMOs)
Others

Based on the Geography:

Ontario
Quebec
Western Canada
British Columbia
Atlantic Canada

Regional Analysis

Ontario

Ontario holds the largest share of the market, accounting for approximately 40% of the total revenue. This dominance is due to the province’s robust biotechnology sector, which includes major pharmaceutical companies, contract manufacturers, and research institutions located primarily in cities such as Toronto. Ontario’s advanced manufacturing infrastructure, combined with substantial investments in biotech and life sciences, positions it as the leading region for single-use bio-processing systems. Furthermore, the province’s strong emphasis on innovation and research, backed by provincial government support, contributes significantly to the continued adoption of single-use technologies.

Quebec

Quebec follows closely behind with a market share of around 30%. The province has a strong pharmaceutical industry presence, particularly in Montreal, which is home to several leading biotechnology firms and research institutions. Quebec’s focus on drug development and its growing reputation as a biotech hub make it a significant player in the Canadian bio-processing market. Additionally, the region’s investment in sustainable manufacturing practices and its emphasis on green technologies support the increasing adoption of single-use systems, which are considered more environmentally friendly compared to traditional bioprocessing methods. This trend is further reinforced by governmental incentives and collaborations with academic institutions.

Western Canada

Western Canada, comprising provinces such as Alberta and Saskatchewan, holds a smaller but steadily growing share, estimated at 15%. This region benefits from the increasing presence of biopharmaceutical manufacturing plants and contract manufacturers in Alberta, as well as investments in biologics production. The development of advanced manufacturing capabilities and process optimization is driving the demand for single-use systems in Western Canada. While it lags behind Ontario and Quebec, Western Canada’s growth is driven by regional expansions, government initiatives promoting the life sciences sector, and increasing adoption of flexible biomanufacturing solutions by smaller biotech firms.

Atlantic Canada

Atlantic Canada represents the smallest share of the market, with approximately 10% of the total market revenue. Despite its smaller size, Atlantic Canada is showing promising growth, particularly in research and development activities related to drug development and biologics. Provinces like Nova Scotia and New Brunswick have been focusing on life sciences innovation, attracting attention from small-to-medium biotech companies. The demand for single-use systems in Atlantic Canada is primarily driven by academic collaborations and emerging biotech ventures. As these companies continue to grow and scale, the adoption of single-use technologies is expected to increase, contributing to the region’s expanding market share.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Thermo Fisher Scientific Inc.
Danaher Corporation
Corning Incorporated
Entegris, Inc.
Meissner Filtration Products, Inc.
Repligen Corporation
PBS Biotech, Inc.
Avantor, Inc.
Saint-Gobain Performance Plastics
Pall Corporation

Competitive Analysis

The Canada Single-Use Bio-Processing Systems market is highly competitive, with several key players leading the industry through innovative solutions and strong market presence. Thermo Fisher Scientific Inc., Danaher Corporation, Corning Incorporated, Entegris, Inc., Meissner Filtration Products, Inc., Repligen Corporation, PBS Biotech, Inc., Avantor, Inc., Saint-Gobain Performance Plastics, and Pall Corporation dominate the market. These companies provide a wide range of single-use products, including bioreactors, mixers, filtration systems, and connectors, essential for scalable and efficient biomanufacturing. The increasing demand for biologics and biosimilars is pushing companies to develop technologies that improve production efficiency, reduce contamination risks, and shorten time-to-market. Additionally, players that focus on enhancing automation, real-time data integration, and flexibility in their systems are gaining traction as manufacturers strive to optimize their processes. The trend toward hybrid biomanufacturing models that combine traditional systems with single-use technologies is also shaping competition, as it allows manufacturers to balance flexibility with cost efficiency.

Research and development investments remain a key competitive strategy, with companies seeking to expand their product portfolios and stay ahead of regulatory requirements. Strategic partnerships, collaborations, and acquisitions also play a vital role in strengthening market positions and ensuring a continuous supply of innovative solutions to meet the growing needs of the biopharmaceutical sector.

Recent Developments

In April 2025, Thermo Fisher Scientific launched the 5L DynaDrive Single-Use Bioreactor, a bench-scale system designed for seamless scalability from 1 to 5,000 liters. This new bioreactor offers a 27% productivity increase over glass bioreactors, enhanced sustainability with biobased films, and consistent performance across different scales, supporting both large and small biopharma manufacturers. The DynaDrive S.U.B. supports robust production across scales and has the flexibility to accommodate a variety of cell lines and processing modalities.
In April 2025, Sartorius Stedim Biotech entered a strategic partnership with Tulip Interfaces to drive digital transformation in single-use bioprocessing. The collaboration introduced Biobrain® Operate powered by Tulip, a suite of digital manufacturing applications that integrate with Sartorius equipment to reduce process variability, digitize operations, and ensure regulatory compliance. This partnership aims to advance paperless manufacturing and optimize resource efficiency in bioprocessing.
In March 2025, Corning introduced new technologies to support advanced therapy applications, including the Ascent™ Fixed Bed Reactor (FBR) and expanded cell expansion platforms like HYPERStack®, HYPERFlask®, and CellSTACK®. These platforms feature closed systems and automation to reduce contamination risk and enhance scalability for bioprocess applications.
In April 2023, Merck KGaA launched the Ultimus® Single-Use Process Container Film, featuring ten times greater abrasion resistance than other films, improved durability, and leak resistance for single-use assemblies. The technology is now available in Mobius® 3D process containers, enhancing operational efficiency and cell growth performance.

Market Concentration & Characteristics

The Canada Single-Use Bio-Processing Systems market exhibits moderate to high concentration, with a few key players dominating the market due to their strong product portfolios, technological expertise, and established customer bases. These players focus on innovation and efficiency to meet the growing demands of biopharmaceutical manufacturing. The market characteristics are shaped by a mix of large multinational corporations and smaller, specialized firms that offer niche solutions. Companies in this sector tend to invest heavily in research and development to expand their product offerings and stay competitive. There is a clear emphasis on automation, real-time data integration, and scalability, which are critical to meeting the increasingly complex needs of biologics and biosimilars production. The market also demonstrates a trend toward hybrid models, combining single-use technologies with traditional manufacturing systems, enabling manufacturers to achieve greater flexibility and cost-efficiency. As the market matures, strategic partnerships and acquisitions are becoming more common to expand market reach and technological capabilities.

Report Coverage

The research report offers an in-depth analysis based on Type, Application, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The market for single-use bio-processing systems in Canada will continue to grow due to the increasing demand for biologics and biosimilars.
Advancements in automation and real-time data analytics will drive greater efficiency and scalability in biomanufacturing.
Hybrid biomanufacturing models, combining single-use and traditional systems, will become more prevalent, offering manufacturers increased flexibility.
The adoption of single-use technologies in downstream processes, such as filtration and mixing, will expand significantly.
There will be a greater emphasis on sustainability, with companies focusing on reducing plastic waste and improving recyclability in single-use systems.
Regulatory support and industry standardization efforts will enhance the safety and reliability of single-use technologies, boosting adoption rates.
Small to mid-sized biotech companies will continue to drive demand for single-use solutions due to their cost-effectiveness and scalability.
Increased investments in R&D by market leaders will lead to innovative products that address specific biomanufacturing challenges.
Strategic collaborations and partnerships between technology providers and biopharmaceutical manufacturers will strengthen market growth.
As the biopharmaceutical industry increasingly focuses on personalized medicine, single-use systems will become more integral to flexible and efficient production processes.

CHAPTER NO. 1 : INTRODUCTION 19

1.1.1. Report Description 19

Purpose of the Report 19

USP & Key Offerings 19

1.1.2. Key Benefits for Stakeholders 19

1.1.3. Target Audience 20

1.1.4. Report Scope 20

CHAPTER NO. 2 : EXECUTIVE SUMMARY 21

2.1. Single-Use Bio-Processing Systems Market Snapshot 21

2.1.1. Canada Single-Use Bio-Processing Systems Market, 2018 – 2032 (USD Million) 22

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 23

3.1. Russia-Ukraine and Israel-Palestine War Impacts 23

CHAPTER NO. 4 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – INDUSTRY ANALYSIS 24

4.1. Introduction 24

4.2. Market Drivers 25

4.2.1. Growing Adoption of Disposable Technologies in Biopharmaceutical Manufacturing 25

4.2.2. Increasing Demand for Cost-Effective and Scalable Bioprocessing Solutions 26

4.3. Market Restraints 27

4.3.1. Concerns Related to Leachables and Extractables in Single-Use Systems 27

4.4. Market Opportunities 28

4.4.1. Advancements in Bioprocessing Technology Driving Innovation in Single-Use Systems 28

4.5. Porter’s Five Forces Analysis 29

4.6. Buying Criteria 30

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 31

5.1. Import Analysis by Canada 31

5.1.1. Canada Single-Use Bio-Processing Systems Market Import Volume/Revenue, By Canada, 2018 – 2023 31

5.2. Export Analysis by Canada 32

5.2.1. Canada Single-Use Bio-Processing Systems Market Export Volume/Revenue, By Canada, 2018 – 2023 32

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 33

6.1. Demand Analysis by Canada 33

6.1.1. Canada Single-Use Bio-Processing Systems Market Demand Volume/Revenue, By Canada, 2018 – 2023 33

6.2. Supply Analysis by Canada 34

6.2.1. Canada Single-Use Bio-Processing Systems Market Supply Volume/Revenue, By Canada, 2018 – 2023 34

CHAPTER NO. 7 : PRODUCTION ANALYSIS 35

7.1. Production Analysis by Canada 35

7.1.1. Canada Single-Use Bio-Processing Systems Market Production Volume/Revenue, By Canada, 2018 – 2023 35

CHAPTER NO. 8 : PRICE ANALYSIS 36

8.1. Price Analysis by Type 36

8.1.1. Canada Single-Use Bio-Processing Systems Market Price, By Type, 2018 – 2023 36

8.1.2. Canada Type Market Price, By Type, 2018 – 2023 36

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 37

9.1. Key Raw Materials and Suppliers 37

9.2. Key Raw Materials Price Trend 37

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 38

10.1. Manufacturing Cost Analysis 38

10.2. Manufacturing Process 38

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 39

11.1. Company Market Share Analysis – 2023 39

11.2. Value Chain Analysis 39

11.2.1. Canada Single-Use Bio-Processing Systems Market: Company Market Share, by Volume, 2023 40

11.2.2. Canada Single-Use Bio-Processing Systems Market: Company Market Share, by Revenue, 2023 41

11.2.3. Canada Single-Use Bio-Processing Systems Market: Top 6 Company Market Share, by Revenue, 2023 41

11.2.4. Canada Single-Use Bio-Processing Systems Market: Top 3 Company Market Share, by Revenue, 2023 42

11.3. Canada Single-Use Bio-Processing Systems Market Company Volume Market Share, 2023 43

11.4. Canada Single-Use Bio-Processing Systems Market Company Revenue Market Share, 2023 44

11.5. Company Assessment Metrics, 2023 44

11.5.1. Stars 44

11.5.2. Emerging Leaders 44

11.5.3. Pervasive Players 44

11.5.4. Participants 44

11.6. Start-ups /SMEs Assessment Metrics, 2023 44

11.6.1. Progressive Companies 44

11.6.2. Responsive Companies 45

11.6.3. Dynamic Companies 45

11.6.4. Starting Blocks 45

11.7. Strategic Developments 46

11.7.1. Acquisitions & Mergers 46

New Product Launch 46

Canada Expansion 46

11.8. Key Players Product Matrix 47

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 48

12.1. PESTEL 48

12.1.1. Political Factors 48

12.1.2. Economic Factors 48

12.1.3. Social Factors 48

12.1.4. Technological Factors 48

12.1.5. Environmental Factors 48

12.1.6. Legal Factors 48

12.2. Adjacent Market Analysis 48

CHAPTER NO. 13 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – BY TYPE SEGMENT ANALYSIS 49

13.1. Single-Use Bio-Processing Systems Market Overview, by Type Segment 49

13.1.1. Single-Use Bio-Processing Systems Market Revenue Share, By Type, 2023 & 2032 50

13.1.2. Single-Use Bio-Processing Systems Market Attractiveness Analysis, By Type 51

13.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 51

13.1.4. Single-Use Bio-Processing Systems Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

13.2. Single-Use Bioreactors 53

13.3. Single-Use Mixers 54

13.4. Single-Use Bags 55

13.5. Single-Use Connectors 56

13.6. Others 57

CHAPTER NO. 14 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – BY APPLICATION SEGMENT ANALYSIS 58

14.1. Single-Use Bio-Processing Systems Market Overview, by Application Segment 58

14.1.1. Single-Use Bio-Processing Systems Market Revenue Share, By Application, 2023 & 2032 59

14.1.2. Single-Use Bio-Processing Systems Market Attractiveness Analysis, By Application 60

14.1.3. Incremental Revenue Growth Opportunity, by Application, 2024 – 2032 60

14.1.4. Single-Use Bio-Processing Systems Market Revenue, By Application, 2018, 2023, 2027 & 2032 61

14.2. Research & Development 62

14.3. Manufacturing 63

14.4. Process Development 64

14.5. Commercial Production 65

14.6. Others 66

CHAPTER NO. 15 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – BY END-USER SEGMENT ANALYSIS 67

15.1. Single-Use Bio-Processing Systems Market Overview, by End-user Segment 67

15.1.1. Single-Use Bio-Processing Systems Market Revenue Share, By End-user, 2023 & 2032 68

15.1.2. Single-Use Bio-Processing Systems Market Attractiveness Analysis, By End-user 69

15.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 69

15.1.4. Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018, 2023, 2027 & 2032 70

15.2. Pharmaceutical & Biotechnology Companies 71

15.3. Contract Research Organizations (CROs) 72

15.4. Academic & Research Institutes 73

15.5. Contract Manufacturing Organizations (CMOs) 74

15.6. Others 75

CHAPTER NO. 16 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – CANADA ANALYSIS 76

16.1. Type 76

16.1.1. Canada Single-Use Bio-Processing Systems Market Revenue, By Type, 2018 – 2023 (USD Million) 76

16.2. Canada Single-Use Bio-Processing Systems Market Revenue, By Type, 2024 – 2032 (USD Million) 76

16.3. Application 77

16.3.1. Canada Single-Use Bio-Processing Systems Market Revenue, By Application, 2018 – 2023 (USD Million) 77

16.3.2. Canada Single-Use Bio-Processing Systems Market Revenue, By Application, 2024 – 2032 (USD Million) 77

16.4. End-user 78

16.4.1. Canada Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018 – 2023 (USD Million) 78

16.4.2. Canada Single-Use Bio-Processing Systems Market Revenue, By End-user, 2024 – 2032 (USD Million) 78

CHAPTER NO. 17 : COMPANY PROFILES 79

17.1. Thermo Fisher Scientific Inc. 79

17.1.1. Company Overview 79

17.1.2. Product Portfolio 79

17.1.3. Swot Analysis 79

17.1.4. Business Strategy 80

17.1.5. Financial Overview 80

17.2. Danaher Corporation 81

17.3. Corning Incorporated 81

17.4. Entegris, Inc. 81

17.5. Meissner Filtration Products, Inc. 81

17.6. Repligen Corporation 81

17.7. PBS Biotech, Inc. 81

17.8. Avantor, Inc. 81

17.9. Saint-Gobain Performance Plastics 81

17.10. Pall Corporation 81

List of Figures

FIG NO. 1. Canada Single-Use Bio-Processing Systems Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for Canada Single-Use Bio-Processing Systems Market 29

FIG NO. 3. Canada Single-Use Bio-Processing Systems Market Import Volume/Revenue, By Canada, 2018 – 2023 31

FIG NO. 4. Canada Single-Use Bio-Processing Systems Market Export Volume/Revenue, By Canada, 2018 – 2023 32

FIG NO. 5. Canada Single-Use Bio-Processing Systems Market Demand Volume/Revenue, By Canada, 2018 – 2023 33

FIG NO. 6. Canada Single-Use Bio-Processing Systems Market Supply Volume/Revenue, By Canada, 2018 – 2023 34

FIG NO. 7. Canada Single-Use Bio-Processing Systems Market Production Volume/Revenue, By Canada, 2018 – 2023 35

FIG NO. 8. Canada Single-Use Bio-Processing Systems Market Price, By Type, 2018 – 2023 36

FIG NO. 9. Raw Materials Price Trend Analysis, 2018 – 2023 37

FIG NO. 10. Manufacturing Cost Analysis 38

FIG NO. 11. Manufacturing Process 38

FIG NO. 12. Value Chain Analysis for Canada Single-Use Bio-Processing Systems Market 39

FIG NO. 13. Company Share Analysis, 2023 40

FIG NO. 14. Company Share Analysis, 2023 41

FIG NO. 15. Company Share Analysis, 2023 41

FIG NO. 16. Company Share Analysis, 2023 42

FIG NO. 17. Single-Use Bio-Processing Systems Market – Company Volume Market Share, 2023 43

FIG NO. 18. Single-Use Bio-Processing Systems Market – Company Revenue Market Share, 2023 44

FIG NO. 19. Single-Use Bio-Processing Systems Market Revenue Share, By Type, 2023 & 2032 50

FIG NO. 20. Market Attractiveness Analysis, By Type 51

FIG NO. 21. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 51

FIG NO. 22. Single-Use Bio-Processing Systems Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

FIG NO. 23. Canada Single-Use Bio-Processing Systems Market for Single-Use Bioreactors, Revenue (USD Million) 2018 – 2032 53

FIG NO. 24. Canada Single-Use Bio-Processing Systems Market for Single-Use Mixers, Revenue (USD Million) 2018 – 2032 54

FIG NO. 25. Canada Single-Use Bio-Processing Systems Market for Single-Use Bags, Revenue (USD Million) 2018 – 2032 55

FIG NO. 26. Canada Single-Use Bio-Processing Systems Market for Single-Use Connectors, Revenue (USD Million) 2018 – 2032 56

FIG NO. 27. Canada Single-Use Bio-Processing Systems Market for Others, Revenue (USD Million) 2018 – 2032 57

FIG NO. 28. Single-Use Bio-Processing Systems Market Revenue Share, By Application, 2023 & 2032 59

FIG NO. 29. Market Attractiveness Analysis, By Application 60

FIG NO. 30. Incremental Revenue Growth Opportunity by Application, 2024 – 2032 60

FIG NO. 31. Single-Use Bio-Processing Systems Market Revenue, By Application, 2018, 2023, 2027 & 2032 61

FIG NO. 32. Canada Single-Use Bio-Processing Systems Market for Research & Development, Revenue (USD Million) 2018 – 2032 62

FIG NO. 33. Canada Single-Use Bio-Processing Systems Market for Manufacturing, Revenue (USD Million) 2018 – 2032 63

FIG NO. 34. Canada Single-Use Bio-Processing Systems Market for Process Development, Revenue (USD Million) 2018 – 2032 64

FIG NO. 35. Canada Single-Use Bio-Processing Systems Market for Commercial Production, Revenue (USD Million) 2018 – 2032 65

FIG NO. 36. Canada Single-Use Bio-Processing Systems Market for Others, Revenue (USD Million) 2018 – 2032 66

FIG NO. 37. Single-Use Bio-Processing Systems Market Revenue Share, By End-user, 2023 & 2032 68

FIG NO. 38. Market Attractiveness Analysis, By End-user 69

FIG NO. 39. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 69

FIG NO. 40. Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018, 2023, 2027 & 2032 70

FIG NO. 41. Canada Single-Use Bio-Processing Systems Market for Pharmaceutical & Biotechnology Companies, Revenue (USD Million) 2018 – 2032 71

FIG NO. 42. Canada Single-Use Bio-Processing Systems Market for Contract Research Organizations (CROs), Revenue (USD Million) 2018 – 2032 72

FIG NO. 43. Canada Single-Use Bio-Processing Systems Market for Academic & Research Institutes, Revenue (USD Million) 2018 – 2032 73

FIG NO. 44. Canada Single-Use Bio-Processing Systems Market for Contract Manufacturing Organizations (CMOs), Revenue (USD Million) 2018 – 2032 74

FIG NO. 45. Canada Single-Use Bio-Processing Systems Market for Others, Revenue (USD Million) 2018 – 2032 75

List of Tables

TABLE NO. 1. : Canada Single-Use Bio-Processing Systems Market: Snapshot 21

TABLE NO. 2. : Drivers for the Single-Use Bio-Processing Systems Market: Impact Analysis 25

TABLE NO. 3. : Restraints for the Single-Use Bio-Processing Systems Market: Impact Analysis 27

TABLE NO. 4. : Canada Single-Use Bio-Processing Systems Market Revenue, By Type, 2018 – 2023 36

TABLE NO. 5. : Key Raw Materials & Suppliers 37

TABLE NO. 6. : Canada Single-Use Bio-Processing Systems Market Revenue, By Type, 2018 – 2023 (USD Million) 76

TABLE NO. 7. : Canada Single-Use Bio-Processing Systems Market Revenue, By Type, 2024 – 2032 (USD Million) 76

TABLE NO. 8. : Canada Single-Use Bio-Processing Systems Market Revenue, By Application, 2018 – 2023 (USD Million) 77

TABLE NO. 9. : Canada Single-Use Bio-Processing Systems Market Revenue, By Application, 2024 – 2032 (USD Million) 77

TABLE NO. 10. : Canada Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018 – 2023 (USD Million) 78

TABLE NO. 11. : Canada Single-Use Bio-Processing Systems Market Revenue, By End-user, 2024 – 2032 (USD Million) 78

Frequently Asked Questions

What is the current size of the Canada Single-Use Bio-Processing Systems?

The Canada Single-Use Bio-Processing Systems market was valued at USD 583.42 million in 2024 and is projected to reach USD 1,845.36 million by 2032, growing at a CAGR of 15.48%.

What factors are driving the growth of the Canada Single-Use Bio-Processing Systems?

Key drivers include rising demand for biologics and biosimilars, cost-efficient biomanufacturing, advancements in automation, and increasing regulatory support.

What are some challenges faced by the Canada Single-Use Bio-Processing Systems?

Challenges include scalability limitations for large-scale production and concerns over plastic waste and environmental sustainability.

Who are the major players in the Canada Single-Use Bio-Processing Systems?

Leading players include Thermo Fisher Scientific, Danaher Corporation, Corning, Pall Corporation, Meissner Filtration Products, and Avantor.

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$8699

Let us help you

WILLIAM, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

EMAIL US

Request Sample

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –